Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Obesity and non-alcoholic steatohepatitis in immunotherapy for hepatocellular carcinoma ; volume:17 ; number:4 ; day:15 ; month:5 ; year:2023 ; pages:827-829 ; date:8.2023
Hepatology international ; 17, Heft 4 (15.5.2023), 827-829, 8.2023
- Urheber
-
Shiina, Shuichiro
Maruyama, Hitoshi
Tobari, Maki
Yamashita, Tatsuya
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s12072-023-10533-w
- URN
-
urn:nbn:de:101:1-2023103111243748664418
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shiina, Shuichiro
- Maruyama, Hitoshi
- Tobari, Maki
- Yamashita, Tatsuya
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas
The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
Impaired Response to Immunotherapy in Non-Alcoholic Steatohepatitis-Related Hepatocellular Carcinoma?
Tumorigenesis from non-alcoholic steatohepatitis to hepatocellular carcinoma
Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma
Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science
Differential methylation patterns in lean and obese non-alcoholic steatohepatitis-associated hepatocellular carcinoma
Non-alcoholic steatohepatitis in pregnancy: a case report
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis
Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice
Aliskiren effect on non-alcoholic steatohepatitis in metabolic syndrome
Diagnostic performance of circulating biomarkers for non-alcoholic steatohepatitis
Aberrant DNA methylation results in altered gene expression in non-alcoholic steatohepatitis-related hepatocellular carcinomas